author-photo

Hanna Rosenbaum

Rappaport Faculty of Medicine
Rambam Health Care Campus

87

Papers

2175

Citations

Citation Trend

Filter By

Papers (57) Sort By

Journal Conference Others

Addendum to Letter to the Editor: Safety, efficacy, and authorization of eliglustat as a first-line therapy in Gaucher disease type 1.

2019 Blood Cells Molecules and Diseases
Show All
- Source
- Cite
- Save
Citations (1)
The Road to Biosimilars in Rare Diseases – Ongoing Lessons from Gaucher Disease

2019 American Journal of Hematology
Show All
- Source
- Cite
- Save
Citations (1)
Safety, efficacy, and authorization of eliglustat as a first-line therapy in Gaucher disease type 1

2018 Blood Cells Molecules and Diseases
Show All
- Source
- Cite
- Save
Citations (14)
Long-term treatment response based on severity of Gaucher disease type 1 at baseline after 8 years of treatment with oral eliglustat: Final efficacy and safety results from a phase 2 clinical trial in treatment-naïve adult patients

2018 Molecular Genetics and Metabolism
Show All
- Source
- Cite
- Save
Citations (0)
Management goals for type 1 Gaucher disease: An expert consensus document from the European working group on Gaucher disease

2018 Blood Cells Molecules and Diseases
Show All
- Source
- Cite
- Save
Citations (44)
Long-term efficacy and safety results of taliglucerase alfa through 5years in adult treatment-naïve patients with Gaucher disease.

2016 Blood Cells Molecules and Diseases
Show All
- Source
- Cite
- Save
Citations (11)
Long-term efficacy and safety results of taliglucerase alfa through 5 years in adult treatment-naïve patients with Gaucher disease

2016 Molecular Genetics and Metabolism
Show All
- Source
- Cite
- Save
Citations (0)
Azacitidine-lenalidomide (ViLen) combination yields a high response rate in higher risk myelodysplastic syndromes (MDS)—ViLen-01 protocol

2016 Annals of Hematology
Show All
- Source
- Cite
- Save
Citations (4)
Long‐term safety and efficacy results of taliglucerase alfa up to 36 months in adult treatment‐naïve patients with Gaucher disease

2016 American Journal of Hematology
Show All
- Source
- Cite
- Save
Citations (10)
Rethinking fatigue in Gaucher disease

2016 Orphanet Journal of Rare Diseases
Show All
- Source
- Cite
- Save
Citations (9)